• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿立哌唑:其药理学及在精神疾病治疗应用中的综述

Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders.

作者信息

Gupta Sanjay, Masand Prakash

机构信息

Department of Psychiatry, University of Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York, USA.

出版信息

Ann Clin Psychiatry. 2004 Jul-Sep;16(3):155-66. doi: 10.1080/10401230490487007.

DOI:10.1080/10401230490487007
PMID:15517848
Abstract

The discovery of antipsychotic medications has revolutionized the treatment of schizophrenia and other psychotic disorders. However, side effects such as extrapyramidal symptoms (EPS) and tardive dyskinesia (TD), electrocardiogram (ECG) changes, weight gain, and metabolic disturbances indicate the continued need to develop new agents. The introduction of atypical drugs such as clozapine, risperidone, olanzapine, quetiapine, and ziprasidone has widened our choices. This article provides an overview of the pharmacology, efficacy, and techniques for the clinical use of aripiprazole, a novel agent with a unique pharmacological profile.

摘要

抗精神病药物的发现彻底改变了精神分裂症和其他精神障碍的治疗方式。然而,诸如锥体外系症状(EPS)、迟发性运动障碍(TD)、心电图(ECG)改变、体重增加和代谢紊乱等副作用表明,仍有持续开发新药物的需求。氯氮平、利培酮、奥氮平、喹硫平和齐拉西酮等非典型药物的引入拓宽了我们的选择范围。本文概述了阿立哌唑的药理学、疗效及临床应用技术,阿立哌唑是一种具有独特药理学特性的新型药物。

相似文献

1
Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders.阿立哌唑:其药理学及在精神疾病治疗应用中的综述
Ann Clin Psychiatry. 2004 Jul-Sep;16(3):155-66. doi: 10.1080/10401230490487007.
2
Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.阿立哌唑:其在精神分裂症和分裂情感性障碍中的应用综述
Drugs. 2004;64(15):1715-36. doi: 10.2165/00003495-200464150-00010.
3
Aripiprazole, a novel atypical antipsychotic drug.阿立哌唑,一种新型非典型抗精神病药物。
Pharmacotherapy. 2004 Feb;24(2):212-28. doi: 10.1592/phco.24.2.212.33145.
4
Aripiprazole: profile on efficacy and safety.阿立哌唑:疗效与安全性概述。
Expert Opin Pharmacother. 2002 Dec;3(12):1773-81. doi: 10.1517/14656566.3.12.1773.
5
Aripiprazole: a review of its pharmacology and clinical use.阿立哌唑:其药理学与临床应用综述
Int J Clin Pract. 2003 Jan-Feb;57(1):49-54.
6
Aripiprazole-induced movement disorder.阿立哌唑所致运动障碍。
Am J Psychiatry. 2006 Jan;163(1):160-1. doi: 10.1176/appi.ajp.163.1.160-a.
7
Tardive dyskinesia in a patient treated with quetiapine.接受喹硫平治疗的患者出现迟发性运动障碍。
World J Biol Psychiatry. 2009;10(1):54-7. doi: 10.1080/15622970701362550.
8
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.第二代抗精神病药物单一疗法在快速控制急性双相躁狂中的作用。
J Clin Psychiatry. 2005;66 Suppl 3:5-11.
9
Aripiprazole: a new atypical antipsychotic drug.阿立哌唑:一种新型非典型抗精神病药物。
Ann Pharmacother. 2003 May;37(5):687-94. doi: 10.1345/aph.1C297.
10
A case of aripiprazole and tardive dyskinesia.一例阿立哌唑与迟发性运动障碍的病例。
J Psychopharmacol. 2009 Mar;23(2):214-5. doi: 10.1177/0269881108089591. Epub 2008 May 30.

引用本文的文献

1
Natural products proposed for the management of Huntington's disease (HD): a comprehensive review.用于治疗亨廷顿舞蹈症(HD)的天然产物:全面综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 17. doi: 10.1007/s00210-025-04444-w.
2
PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?PI3K-AKT/mTOR 信号通路在精神障碍中的作用:刺激还是抑制?
Int J Neuropsychopharmacol. 2024 Feb 1;27(2). doi: 10.1093/ijnp/pyae010.
3
Pharmacogenetics in the Treatment of Huntington's Disease: Review and Future Perspectives.
亨廷顿舞蹈病治疗中的药物遗传学:综述与未来展望
J Pers Med. 2023 Feb 22;13(3):385. doi: 10.3390/jpm13030385.
4
Case report: Treatment of psychiatric symptoms for an acromegalic patient with pituitary adenoma.病例报告:垂体腺瘤所致肢端肥大症患者精神症状的治疗
Front Psychiatry. 2022 Dec 1;13:1068836. doi: 10.3389/fpsyt.2022.1068836. eCollection 2022.
5
Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats.NRG1/ErbB4 和 PI3K/AKT/mTOR 信号通路在阿立哌唑和司替螺酮抗氯胺酮诱导的大鼠精神分裂样行为中的抗精神病作用中的作用。
Inflammopharmacology. 2022 Oct;30(5):1891-1907. doi: 10.1007/s10787-022-01031-w. Epub 2022 Jul 25.
6
Aripiprazole-induced transient myopia.阿立哌唑所致短暂性近视。
North Clin Istanb. 2019 Jul 12;7(5):516-518. doi: 10.14744/nci.2019.65625. eCollection 2020.
7
Two instances of improvement in tardive dyskinesia after administration of aripiprazole in a single patient.一名患者在服用阿立哌唑后迟发性运动障碍出现两次改善情况。
Prim Care Companion CNS Disord. 2012;14(6). doi: 10.4088/PCC.11l01315.
8
Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.阿立哌唑治疗双相情感障碍的疗效和安全性:系统评价。
Ann Gen Psychiatry. 2009 Jul 27;8:16. doi: 10.1186/1744-859X-8-16.
9
Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats.新型抗精神病药物氨磺必利和阿立哌唑对大鼠母性行为的影响。
Psychopharmacology (Berl). 2005 Sep;181(3):600-10. doi: 10.1007/s00213-005-0091-7. Epub 2005 Oct 12.